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ABSTRACT
Peptidases, their substrates and inhibitors are of
great relevance to biology, medicine and biotech-
nology. The MEROPS database (http://merops
.sanger.ac.uk) aims to fulfil the need for an
integrated source of information about these. The
database has hierarchical classifications in which
homologous sets of peptidases and protein inhibi-
tors are grouped into protein species, which are
grouped into families, which are in turn grouped
into clans. The database has been expanded to
include proteolytic enzymes other than peptidases.
Special identifiers for peptidases from a variety of
model organisms have been established so that
orthologues can be detected in other species. A
table of predicted active-site residue and metal
ligand positions and the residue ranges of the pep-
tidase domains in orthologues has been added to
each peptidase summary. New displays of tertiary
structures, which can be rotated or have the
surfaces displayed, have been added to the struc-
ture pages. New indexes for gene names and pep-
tidase substrates have been made available. Among
the enhancements to existing features are the inclu-
sion of small-molecule inhibitors in the tables of
peptidase–inhibitor interactions, a table of known
cleavage sites for each protein substrate, and
tables showing the substrate-binding preferences
of peptidases derived from combinatorial peptide
substrate libraries.
INTRODUCTION
The MEROPS database is a manually curated informa-
tion resource for proteolytic enzymes, their inhibitors and
substrates. The database can be found at http://merops
.sanger.ac.uk.
A proteolytic enzyme breaks down a polypeptide or
protein by cleaving peptide bonds. Proteolytic enzymes
are needed for the survival of all living organisms, and
are of importance to mankind in the ﬁelds of medicine,
nutrition, agriculture and technology (1).
The MEROPS database provides a classiﬁcation and
nomenclature of proteolytic enzymes and their inhibitors
that is widely used throughout the academic community.
The classiﬁcation of proteolytic enzymes is derived from
the system developed by Rawlings and Barrett (2). When
it became apparent that paper publications to update the
classiﬁcation were no longer adequate, the database was
developed at the Babraham Institute (3). The database
moved to the Wellcome Trust Sanger Institute in 2002
(4). A classiﬁcation of the protein inhibitors of peptidases
(5) was added in 2004 (4) and coverage of the mostly
synthetic, small-molecule inhibitors (SMIs) was added in
2008 (6).
Knowledge of the cleavages within protein, peptide and
synthetic substrates is important for understanding the
speciﬁcity and physiological roles of proteolytic enzymes,
so the MEROPS database also includes a collection of
known cleavage sites in substrates (7). Peptidase speciﬁcity
is shown as a WebLogo display (8) and as a table of pref-
erences for each substrate-binding pocket (6).
THE MEROPS CLASSIFICATION SYSTEMS
Proteolytic enzymes are frequently multi-domain proteins,
with peptidase activity restricted to a single structural
domain. Protein inhibitors are also frequently multi-
domain proteins, often containing multiple, homologous
inhibitor domains. Throughout the MEROPS database,
only that portion of the sequence corresponding to a
single peptidase domain (the ‘peptidase unit’) or a single
inhibitor domain (the ‘inhibitor unit’) is used in sequence
and structure comparisons.
The classiﬁcations are hierarchical. At the bottom of
each hierarchy is the peptidase or inhibitor unit. The
protein to which it belongs that has been most fully
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called a ‘holotype’. Sequences considered to represent the
same protein but from different organisms (i.e.
orthologues) are grouped as a single protein species ac-
cording to the criteria set out by Barrett and Rawlings
(9). A new holotype (and protein species) is identiﬁed
when a protein has been biochemically demonstrated to
have a different speciﬁcity from any other member of the
same family. For a peptidase, either it cleaves different
substrates, cleaves the same substrates in different
places or interacts with a different set of inhibitors; for
an inhibitor, it interacts with a different set of peptidases
or binds a peptidase much more tightly. A new identiﬁer is
also created if the characterized protein has a different
architecture, or does not cluster on an evolutionary tree
with other characterized proteins. The numbers of identi-
ﬁers set up for peptidases and inhibitors are shown in
Table 1.
Homologues [detectable by a sequence similarity search
using FastA (10), BlastP (11) or HMMER (12)] are
grouped into a family. A family contains any number of
homologues. One sequence is chosen as the type example
of the family, and all sequences in the family are homolo-
gous to this type example, either directly or transitively. A
sequence is included in the family if a pairwise alignment
with an existing member of the family shows a statistically
signiﬁcant match, i.e. the expect value is <0.001.
The highest level of the hierarchy is that of clan, and all
sequences within a clan are believed to be derived from the
same ancestor, even if there is no signiﬁcant sequence simi-
larity. The most rigorous criterion for including proteins
in the same clan is a similar tertiary structure. The DALI
algorithm and server (13) is used to compare structures,
and if the z-score from the DALI comparison to that of an
existing member of a clan is >6.0, the sequence is added to
that clan. The order of active-site residues is conserved in
all members of a clan, and where no tertiary structure is
known, a family may be added to a clan if this is the same.
A clan can consist of a single family if the tertiary struc-
ture of a member is unrelated to that of any other peptid-
ase or protein inhibitor.
Table 1 shows statistics for release 9.5 of the MEROPS
database. In the 2 years since the previous article (14),
despite the number of sequences in the database having
increasing by over a third, only 18 new families and 4 new
clans have been added.
RECENT DEVELOPMENTS
The website has been redesigned and improved. Frames
have been removed from some HTML pages so that a user
can bookmark any page. In addition, a Request Tracker
ticketing system has been introduced to allow users to
make comments and suggestions and to report errors.
This can be accessed via a ‘feedback’ link present in the
footer of every page.
The database has been extended to include proteolytic
enzymes other than peptidases. Families of self-cleaving
proteins that utilize the peculiar chemistry of asparagine
to break peptide bonds without hydrolysis, known as ‘as-
paragine peptide lyases’ (15) have been added to the
database.
Indexes are now provided for peptidase substrates (see
below) and gene names of peptidases and protein inhibi-
tors. The gene name index also includes synonyms of the
names and the locus names from completely sequenced
genomes. The names are listed alphabetically, along with
the source organism (with a clickable link to the organism
page in MEROPS) and the protein name recommended by
the MEROPS team (with a clickable link to the summary
page in MEROPS).
The MEROPS database includes over 44000 literature
references, and in addition to links to PubMed and to the
text of papers from journal websites made available via
DOI (digital object identiﬁer), links are now made to the
free text articles in PubMed Central (16). We have also
implemented a new facility to search our literature collec-
tion for a speciﬁc PubMed identiﬁer. This is available via
the ‘Searches’ option on the left-hand menu. On entering a
PubMed identiﬁer the full reference is returned, plus a list
of peptidases and inhibitors for which this reference is
cited in MEROPS, with a link to the MEROPS
summary page for each.
Cross-references to other databases
A number of new cross-references have been established
between items in the MEROPS database and other
publicly available databases. Over 200 cross-references
to Wikipedia articles have been set-up for individual pep-
tidases and inhibitors on the relevant summary pages, with
reciprocal links within those Wikipedia pages. New
cross-references have been established between SMIs and
the ChEBI (17) and DrugBank (18) databases, with 100
and 40 cross-references, respectively.
Sequence features
A new page giving details of species variants of peptidases
has been created. Whenever a sequence is added to the
MEROPS collection, several parameters are calculated
from a BlastP pairwise comparison, including the
position of active-site residues and the extent of the pep-
tidase unit. The Sequence Features page presents the
results as a table (Figure 1). Each row in the table shows
the following information: the MEROPS sequence identi-
ﬁer, the scientiﬁc name of the source organism, the
sequence length, the extent of the peptidase (or inhibitor)
unit relative to the complete coding sequence, the
Table 1. Counts of protein species, families and clans for proteolytic
enzymes and protein inhibitors in the MEROPS database
MEROPS 8.5 MEROPS 9.5
Peptidases Inhibitors Peptidases Inhibitors
Sequences 140313 16337 192053 17451
Protein species 3243 589 4202 634
Families 211 67 225 71
Clans 42 32 44 34
The numbers in Release 9.5 of MEROPS (July 2011) are compared to
those in Release 8.5 (August 2009).
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metallopeptidase) and the source of the sequence
included in the MEROPS collection with a link to the
relevant database. The organism scientiﬁc name is click-
able and takes the user to the relevant organism page in
MEROPS. For the active-site residues and metal ligands,
each amino acid is shown in single letter code next to the
residue number derived from the source sequence. If the
sequence is a fragment or from a eukaryotic genome
sequencing project where the automated gene build has
missed an exon, then absent active-site residues are
labeled ‘missing’. The items are arranged alphabetically
by species scientiﬁc name, but can be re-sorted by the
MEROPS sequence identiﬁer.
Tertiary structure displays
When the tertiary structure of a peptidase or a protein
inhibitor has been solved, and the co-ordinates are avail-
able from the Protein Data Bank (PDB) (19), a structure
page is presented at the MEROPS website. Besides a table
of PDB entries, this has also included a ﬁxed Richardson
image (20) showing the structure with helices shown as red
coils and strands as green arrows, with the active-site
residues (and metal ligands for metallopeptidases) in
ball-and-stick representation. Metal ions, attached carbo-
hydrates, and inhibitors are also displayed where appro-
priate. However, a rotating image provides more insight
into a protein structure, and so we now present a rotating
image using AstexViewer (21) alongside the ﬁxed image.
The same structural elements, residues, metals and carbo-
hydrates are shown in both images, because the command
line input for the AstexViewer is derived from the input
ﬁle used for the Richardson image. There is an option to
show the surface of the molecule, and the image can be
rotated in any direction by clicking on the image and
holding down the left mouse button. Various other
options are available by clicking on the right mouse
button, including changing colors, saving the image and
measuring the distances between atoms. To be able to use
the AstexViewer, users must have Java installed. An
example of the images on a structure page is shown in
Figure 2.
MERNUM  Species  Sequence length Peptidase unit Active site residues  Metal ligands  Source 
MER199117  Ailuropoda melanoleuca 679  17-679  E469,    H468,  H472,  E497,  GENBANK:EFB13539 
MER107691  Brachydanio rerio  686  19-683  E471  H470, H474, E499  GENBANK:AAH75901 
MER101043  Ciona intestinalis  691 10-690  E459  H458,  H462,  missing ENSEMBL:ENSCINP00000017102 
MER157852  Dipodomys ordii  686  78-685  E474  H473, H477, E502  ENSEMBL:ENSDORP00000008420
MER098455  Equus caballus  687  2-686  E474  H473, H477, E502  GENBANK:XP_001493585 
MER100935  Gasterosteus aculeatus  685  5-675  E470  H469, H473, E498  ENSEMBL:ENSGACP00000004264
MER001737  Homo sapiens  689  2-687  E474  H473, H477, E502  UNIPROT:P52888 
MER112464  Macaca mulatta  648  2-648  G478  C477, E481, E506  GENBANK:XP_001117760 
MER014510  Mus musculus  687  2-687  E474  H473, H477, E502  UNIPROT:Q9EPX1 
MER100960  Myotis lucifugus  686  2-680  E473  H472, H476, E501  ENSEMBL:ENSMLUP00000013017
MER101030  Oryzias latipes  687  21-684  E472  H471, H475, E500  ENSEMBL:ENSORLP00000002985
MER001149  Rattus norvegicus  687  2-687  E474  H473, H477, E502  UNIPROT:P24155 
MER164477  Salmo salar  685  19-682  E470  H469, H473, E498  GENBANK:NP_001133368 
MER103219  Schistosoma japonicum  334  3-326  E127  H126, H130, E155  GENBANK:AAX26445 
MER101024  Sorex araneus  665  1-665  E463  H462, H466, E491  ENSEMBL:ENSSARP00000009994
MER113852  Strongylocentrotus purpuratus  307  37-307  E141  H140, H144, E169  GENBANK:XP_790202 
MER001150  Sus scrofa  687  2-687  E474  H473, H477, E502  UNIPROT:P47788 
MER177631  Taeniopygia guttata  717  39-709  E504  H503, H507, E532  GENBANK:XP_002194663 
MER107706  Tetraodon nigroviridis  701  1-701  E458  H457, H461, Q488  GENBANK:CAF91485 
MER012094  Xenopus laevis  685  1-684  E471  H470, H474, E499  UNIPROT:Q9PTV2 
MER079236  Xenopus tropicalis  684  7-683  E470  H469, H473, E498  UNIPROT:UPI00006A14DA 
Figure 1. Sequence features display. The sequence features are shown for orthologues of thimet oligopeptidase.
Nucleic Acids Research, 2012,Vol.40, Database issue D345Figure 2. Displays of tertiary structure. The Structure page for thermolysin (M04.001) is shown. The table provides the cross-reference to the PDB
entry, source organism, resolution, a comment and a description of the elements displayed in the images below. The image on the left-hand side is a
rendered Richardson image generated using the programs RasMol (22), Molscript (23) and Render (24). The image on the right shows the surface of
the molecule using the AstexViewer. This image can be rotated in any direction by the user, and the surface hidden by clicking the ‘hide surface’
button. The third image shows secondary structure, active-site residues and metal ligands as they appear in the protein sequence.
Figure 3. Growth in number of determined putative peptidase sequences. The curves shown are (A) all sequences, (B) sequences assigned to
identiﬁers, (C) sequences assigned to identiﬁers excluding model organisms, (D) all identiﬁers and (E) identiﬁers excluding model organisms.
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Homologues of peptidases and protein inhibitors are
being sequenced much faster than they can be
characterized. Consequences of this can be seen in
Figure 3, which shows the cumulative totals of homo-
logues of peptidase sequences in the MEROPS database
since 1998, and the total number of MEROPS peptidase
identiﬁers per year. It also shows the number of homo-
logues that have been assigned to identiﬁers. Although
MEROPS identiﬁers can be applied to species variants,
the number of sequences that are unassigned is increasing
rapidly. Less than half of all putative peptidases can be
classiﬁed at the peptidase level, because the sequences are
too divergent from that of the holotypes or the protein
architecture is signiﬁcantly different. This has led us to
search for methods to draw attention to enzymes that
may be suited to biochemical study because they come
from well-characterized model organisms. An approach
that we have adopted is to extend the concept of the
holotype to these uncharacterized proteins. Special
MEROPS identiﬁers have been created for all the
uncharacterized peptidase homologues from a variety
of model organisms: human, mouse, Drosophila
melanogaster, Caenorhabditis elegans, Arabidopsis
thaliana, Saccharomyces cerevisiae and Escherichia coli.
These special identiﬁers resemble the standard
MEROPS identiﬁer except that the ﬁrst character after
the dot is the letter ‘A’ or ‘B’ so that it is easy to distin-
guish an identiﬁer for a characterized peptidase from that
of an uncharacterized one. Such special identiﬁers have
not been set up for protein inhibitors or non-peptidase
homologues. Table 2 shows the number of peptidases
and putative peptidases in each model organism. In
total, 1248 special identiﬁers have been created. Creation
of special identiﬁers is useful if orthologues from other
species can be identiﬁed, because a widely distributed
Figure 4. Display of cleavages in a protein substrate. Known cleavages in the DSPP600 protein from pig are shown. The full sequence is shown at
the top with cleaved bonds indicated by the ‘dagger’ symbol. More details of each cleavage are shown in the table beneath.
Table 2. Counts of peptidase-encoding genes in selected model
organisms
Organism Sequences
assigned
to standard
MEROPS
identiﬁers
Sequences
assigned
to special
MEROPS
identiﬁers
Total
Homo sapiens 557 1 558
Mus musculus 553 14 567
Drosophilia melanogaster 111 320 431
Caenorhabditis elegans 74 273 347
Arabidopsis thaliana 125 452 577
Saccharomyces cerevisiae 76 25 101
Escherichia coli 88 167 255
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characterized. The special identiﬁers C26.A17 (GuaA
protein, E. coli), C26.A19 (PabA protein, E. coli) and
M20.A11 (AbgB protein, E. coli) have each been applied
to putative proteins from over 500 species. Figure 3 also
shows how these special identiﬁers have helped us to
cluster putative peptidase sequences as species variants.
When a peptidase assigned to a special identiﬁer is bio-
chemically characterized, a standard type of MEROPS
identiﬁer will be assigned to replace the special one.
Small-molecule peptidase inhibitors
A new series of identiﬁers has been created for SMIs.
SMIs include naturally occurring compounds such as
pepstatin, bestatin and amastatin, as well as synthetic in-
hibitors generated in a laboratory, and so do not lend
themselves to any form of natural classiﬁcation, unlike
the peptidases and protein inhibitors. Instead, each SMI
is assigned an identiﬁer consisting of an initial J followed
by a ﬁve digit number. For example, pepstatin is J00095
and ethylenediaminetetraacetic acid is J00149. This allows
users to connect directly to an SMI summary.
The page of inhibitor interactions, available from most
peptidase summaries, now includes small molecule as well
as protein inhibitors. These interactions have been col-
lected from the literature. For each SMI, a link has been
provided to the relevant summary.
Peptidase substrates
Our collection of known cleavage sites in substrates
consists of 54837 cleavages in release 9.5, of which
48557 (88.5%) were mapped to identiﬁers in the
UniProt database (representing cleavages in 14446 differ-
ent proteins). The remaining 6281 (11.5%) represent
cleavages in synthetic substrates. This is an increase of
15191 cleavages (27.7%) since release 8.5 (August 2009).
Substrates have been tagged as physiological, non-
physiological, pathologic and synthetic, as judged by the
original authors, unless there is evidence to indicate other-
wise. It is now possible to ﬁlter the substrates listed for
each peptidase so that only physiologically relevant,
pathologic, non-physiological or synthetic substrates are
shown.
An index of substrate names is now available. This
lists the name, the UniProt accession, the peptidase
known to cleave that substrate with a link to the
summary for that peptidase, and a count of cleavages per-
formed by each peptidase. On clicking the UniProt iden-
tiﬁer, the user is presented with a display showing the
cleavages within the sequence and a table of cleavages.
The table shows:
(i) the residue number of the amino acid in the P1
position (i.e. on the left of the scissile bond);
(ii) the name of the peptidase responsible (with a link
to the relevant peptidase summary);
Specificity from combinatorial peptides
Organism  comment P4 P3 P2 P1 P1' P2' P3' P4'
optimal 
substrate 
fluorophore
or
acceptor-
donor pair
Reference
Carica
papaya
wild type P P V R/Q/A A/S/T  S/R G/K/P/R P/Q/N PPVR ASGP
Abz-
Tyr(NO2) 
St Hilaire 
et al.,
1999
Carica
papaya
wild type P/G/H/broad P/R V R/K - -  -  -  PPVR  ACC 
Choe et
al., 2006
Carica
papaya
wild type  -  -  -  K - -  -  - xxxK xxxx  ACC-Dabcyl
Sun et al.,
2007
Carica
papaya
wild type  -  -  -  Iaf/R - -  -  - xxxIaf xxxx  Abz-EDDnp
Alves et
al., 2001
Carica
papaya
wild type  -  -  -  -  L/A/S/F - -  -  xxxx Lxxx  Dansyl-Trp 
Ménard et
al., 1993
Carica
papaya
wild type  -  -  -  -  L - -  -  xxxx Lxxx  Abz-EDDnp
Melo et
al., 2001
Carica
papaya
wild type  -  -  -  G - -  -  - xxxG xxxx  Abz-EDDnp
Del Nery 
et al.,
2000
Figure 5. Speciﬁcity from combinatorial peptide libraries. The amino acid preferences within each substrate-binding pocket (labeled P4–P40) are
shown for experiments using combinatorial libraries of peptide substrates for the peptidase papain.
D348 Nucleic AcidsResearch, 2012, Vol.40,Database issue(iii) the residue range of the substrate used in the ex-
periment compared to the complete coding
sequence that is presented in the UniProt entry
(e.g. minus a signal peptide or propeptide for a
mature protein);
(iv) whether the cleavage is thought to be physiological
or not;
(v) how the cleavage was determined (using the fol-
lowing symbols: NT for N-terminal sequencing,
MS for mass spectroscopy, MU for site-directed
mutagenesis and CS for theoretical cleavages
that ﬁt the consensus sequence of a peptidase
substrate);
(vi) a comment describing the purpose of the cleavage
(e.g. ‘release of a signal peptide’); and
(vii) a reference.
An example of cleavages annotated in a protein substrate
is shown in Figure 4.
The identiﬁcation of cleavage sites in substrates is
important not only for determining the physiological
roles of peptidases, but also for determining the speciﬁcity
of the peptidase, which can help in the design of better and
more selective synthetic substrates and inhibitors. There
are now high-throughput techniques for determining pep-
tidase speciﬁcity which automatically calculate preferences
for each substrate-binding pocket, but do not determine
the cleavage position in each synthetic peptide. An array
of different peptides is made that is known as a ‘combina-
torial library of substrates’. Because the cleavage position
and sequence of each substrate is not known, these cannot
be entered into the MEROPS collection of substrate cleav-
ages. However, Poreba and Drag (2010) (25) have
assembled a collection of peptidase preferences from the
available literature, and made them available to
MEROPS. These are presented as a table on each
relevant peptidase summary. The table lists the source
organism of the peptidase, a comment (such as whether
the peptidase was wild-type or recombinant), the speciﬁ-
city in terms of substrate-binding pockets P4 to P4’ with
the preferred amino acids shown in single letter code, the
optimal substrate derived from the study, the ﬂuorophore
attached to the substrate or the acceptor–donor pair of a
quenched ﬂuorescent substrate, and a reference. Figure 5
shows an example of the new combinatorial peptides
display.
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